1. ALLA AKTIER
  2. NYHETER
  3. BIOTAGE

Biotage

Nyheter Biotage Nyheter alla bolag
eToro Trading Platform Advertisement
Slipp dessa annonser och få en massa andra godsaker med vårt premiumabonnemang.

Invitation to Biotage's presentation of the results for the third quarter of 2022 on November 2 at 16:00 CET

Biotage publishes its report for the third quarter of 2022 on November 2, 2022 at 15.00 CET. At 16.00 CET the same day, a webcast telephone conference will be held where CEO Tomas Blomquist and CFO Maja Nilsson will present the report. The presentation is followed by a question and answer session.

The presentation will be held in English. Information, telephone number and link to the presentation can be found at the following web link: https://financialhearings.com/event/44364

The presentation material will be available before the start of the conference on Biotage's website https://www.biotage.com/en/investor-relations-home. It will also be possible to see the recorded version of the webcast afterwards.

Contacts

Tomas Blomquist, President and CEO
Tel: 0705 23 01 63, tomas.blomquist@biotage.com

Maja Nilsson, CFO
Tel: 0733 25 51 70, maja.nilsson@biotage.com

About Biotage

Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.

Biotage is contributing to sustainable science with the goal to make the world a healthier, greener and cleaner place – HumanKind Unlimited.

Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.

Biotage is headquartered in Uppsala in Sweden and employs 497 people worldwide. The Group had sales of 1,232 MSEK in 2021 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.
Website: www.biotage.com

Attachments

Invitation to Biotage's presentation of the results for the third quarter of 2022 on November 2 at 16:00 CET

Datum 2022-10-25, kl 11:00
Källa MFN
Bifogade filer
Invitation to Biotage's presentation of the results for the third quarter of 2022 on November 2 at 16:00 CET